Diebold Nixdorf Shares Pop On Rating Upgrade: Key Takeaways
Wedbush analyst Matt Bryson upgraded Diebold Nixdorf Inc (NYSE: DBD) from Neutral to Outperform with a $5 price target. The projection reflected its strong…
Raymond James Initiates Coverage On This Stock With Bullish Pitch On Gene Therapies
Raymond James initiated coverage on Rocket Pharmaceuticals Inc (NASDAQ: RCKT) with an Outperform rating with a $22 price target based on the positive view of RP-L102 and RP-L201 gene therapy programs and LAD-I.
Where DuPont de Nemours Stands With Analysts
Analysts have provided the following ratings for DuPont de Nemours (NYSE:DD) within the last quarter:
4 Analysts Have This to Say About W.P. Carey
Analysts have provided the following ratings for W.P. Carey (NYSE:WPC) within the last quarter:
Where Seagen Stands With Analysts
Seagen (NASDAQ:SGEN) has observed the following analyst ratings within the last quarter:
4 Analysts Have This to Say About Realty Income
Realty Income (NYSE:O) has observed the following analyst ratings within the last quarter:
Expert Ratings for Cedar Fair
Within the last quarter, Cedar Fair (NYSE:FUN) has observed the following analyst ratings:
Needham Cuts Price Target On This NASH-Focused Stock As Its Awaits Visibility On Regulatory Path
Yesterday, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced data from the new interim analysis of the Phase 3 REGENERATE trial evaluating obeticholic acid in…
Telsey Advisory Says Costco Is ‘Executing Well’; Sees Notable Upside
Telsey Advisory Group analyst Joseph Feldman reiterated its Outperform rating on Costco Wholesale Corp (NASDAQ:COST) shares with a price target of $590 (17%…
Cathie Wood’s Ark Expects Roku Stock To Soar About 550% In 4 Years
Shares of streaming device maker Roku, Inc. (NASDAQ: ROKU) could be in for a strong upside over the next five years, according to analysts from Cathie Wood's Ark Invest.